IP Library Patent Application 17361611
Patent Application
App. No. 17/361,611

PERIVASCULAR STROMAL CELLS FROM PRIMATE PLURIPOTENT STEM CELLS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/361,611
Abstract

The invention provides methods, compositions and kits for making and using pericyte-like cells or perivascular stromal cells derived from pPS cells.

Claims (9)

1 .- 12 . (canceled)

13 . A method for differentiating pluripotent stem cells into pericyte-like cells, the method comprising: 1) obtaining embryoid bodies from pluripotent stem cells; 2) seeding embryoid bodies at high density in low attachment plates; 3) culturing the embryoid bodies in suspension in the presence of appropriate factors; and 4) dissociating the embryoid bodies and transferring the dissociated cells to adherent plates for further culturing in the presence of appropriate factors.

14 . The method of claim 13 , wherein the seeding density of step 2) is at least 1.5×10 6 cells/mL.

15 . The method of claim 13 , wherein the seeding density of step 2) is at least 3×10 6 cells/mL.

16 . The method of claim 13 , wherein the cells are cultured in the presence of a BMP.

17 . The method of claim 16 , wherein the BMP is BMP-4.

18 . The method of claim 13 , wherein further culturing of step 4 is performed in a medium comprising bFGF, optionally also comprising VEGF-A, optionally also comprising a TGFβ signaling inhibitor.

19 . The method of claim 13 , further comprising an additional step of dissociating and harvesting of cells of step 4, and expanding said cells by further culturing on adherent plates in the presence of appropriate factors.

20 . The method of claim 19 , wherein the additional step is performed in a medium not comprising BMP.

Assignments (2)
SECURITY INTEREST Recorded Nov 10, 2023
From: AGEX THERAPEUTICS, INC.; RECYTE THERAPEUTICS, INC.; REVERSE BIOENGINEERING, INC.
To: JUVENESCENCE LIMITED
Reel/Frame 065529/0594 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2021
From: YANG, JIWEI; LAROCCA, DANA; GREENWOOD-GOODWIN, MIDORI
To: RECYTE THERAPEUTICS, INC.
Reel/Frame 057052/0268 →